3648-30-4Relevant academic research and scientific papers
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1
Chen, Allie Y.,Thomas, Pei W.,Stewart, Alesha C.,Bergstrom, Alexander,Cheng, Zishuo,Miller, Callie,Bethel, Christopher R.,Marshall, Steven H.,Credille, Cy V.,Riley, Christopher L.,Page, Richard C.,Bonomo, Robert A.,Crowder, Michael W.,Tierney, David L.,Fast, Walter,Cohen, Seth M.
, p. 7267 - 7283 (2017)
The efficacy of β-lactam antibiotics is threatened by the emergence and global spread of metallo-β-lactamase (MBL) mediated resistance, specifically New Delhi metallo-β-lactamase-1 (NDM-1). By utilization of fragment-based drug discovery (FBDD), a new class of inhibitors for NDM-1 and two related β-lactamases, IMP-1 and VIM-2, was identified. On the basis of 2,6-dipicolinic acid (DPA), several libraries were synthesized for structure-activity relationship (SAR) analysis. Inhibitor 36 (IC50 = 80 nM) was identified to be highly selective for MBLs when compared to other Zn(II) metalloenzymes. While DPA displayed a propensity to chelate metal ions from NDM-1, 36 formed a stable NDM-1:Zn(II):inhibitor ternary complex, as demonstrated by 1H NMR, electron paramagnetic resonance (EPR) spectroscopy, equilibrium dialysis, intrinsic tryptophan fluorescence emission, and UV-vis spectroscopy. When coadministered with 36 (at concentrations nontoxic to mammalian cells), the minimum inhibitory concentrations (MICs) of imipenem against clinical isolates of Eschericia coli and Klebsiella pneumoniae harboring NDM-1 were reduced to susceptible levels.
